Repertoire Immune Medicines
Pre-clinicalRepertoire Immune Medicines is a clinical-stage biotechnology company working to unlock and direct the remarkable power of the human immune system to prevent or treat cancer, as well as autoimmune and infectious disease.
Founded
2018
Focus
RNA & Gene TherapyCell & Gene Therapy
About
Repertoire Immune Medicines is a clinical-stage biotechnology company working to unlock and direct the remarkable power of the human immune system to prevent or treat cancer, as well as autoimmune and infectious disease.
Funding History
2Total raised: $259M
Series B$189MSoftBank Vision Fund 2Jun 15, 2021
Series A$70MFlagship PioneeringJan 15, 2020
Company Info
TypePrivate
Founded2018
LocationCambridge, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile